Taiko Pharmaceutical Co.,Ltd.
Taiko Pharmaceutical Co.,Ltd.
Share · JP3442200006 (XTKS)
Overview
No Price
Closing Price XTKS 06.03.2026: 298,00 JPY
06.03.2026 05:43
Current Prices from Taiko Pharmaceutical Co.,Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
4574.T
JPY
06.03.2026 05:43
298,00 JPY
-
Share Float & Liquidity
Free Float 70,81 %
Shares Float 35,58 M
Shares Outstanding 50,25 M
Invested Funds

The following funds have invested in Taiko Pharmaceutical Co.,Ltd.:

Fund
iShares Core MSCI Japan IMI UCITS ETF USD (Dist)
Vol. in million
6,35
Percentage (%)
0,0034 %
Fund
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged (Acc)
Vol. in million
2,59
Percentage (%)
0,0034 %
Company Profile for Taiko Pharmaceutical Co.,Ltd. Share
Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`
AI Analysis of Taiko Pharmaceutical Co.,Ltd.
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Taiko Pharmaceutical Co.,Ltd.
No AI threads available for this company yet.

Company Data

Name Taiko Pharmaceutical Co.,Ltd.
Company Taiko Pharmaceutical Co.,Ltd.
Website https://www.seirogan.co.jp
Primary Exchange XTKS Tokyo
ISIN JP3442200006
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Takashi Shibata
Market Capitalization 15 Mrd.
Country Japan
Currency JPY
Employees 0,2 T
Address 1-4-1, Nishi-Honmachi, 550-0005 Osaka
IPO Date 2009-03-18

Stock Splits

Date Split
28.07.2009 3:1

Ticker Symbols

Name Symbol
Tokyo 4574.T
More Shares
Investors who hold Taiko Pharmaceutical Co.,Ltd. also have the following shares in their portfolio:
63 Moons Technologies Limited
63 Moons Technologies Limited Share
AUD/AED UAE DIRHAM
AUD/AED UAE DIRHAM Currency
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026